Targacept Cuts 46 Pct. of Jobs; Amgen Makes $700 Million Buy - Apr. 25, 2012

Having trouble viewing this email? View in Browser.

Wednesday, April 25, 2012  |   |   |   |  Challenging Current Paradigms in Early Drug Development Please Join Aptuit at their Medicines Research Centre in Verona Italy Drug Discovery and Development is an expensive and high-risk business that can take 10 years from inception to the commercialization of a new drug. Often associated with high attrition rates, it is driven by medical need, disease prevalence and likelihood of success. Drug Development has traditionally been a long and extensive process designed for a staged assessment of the safety, efficacy and manufacture of a drug candidate. On May 16, 2012, Aptuit will welcome nine distinguished representatives from academia and industry to speak at this FREE symposium where they will cover and discuss aspects and strategies to reduce risk, costs and timelines from Candidate Selection to Phase II Clinical Trials. For a full description of this event, and to register, please go to: www.aptuit.com/verona/paradigms/introduction.aspx.   •  Targacept, Inc. (TRGT) Cuts 46 Pct. of Jobs More... •  Amgen (AMGN) Makes $700 Million Buy More... •  Novartis AG (NVS) Tries More Exec Level OTC Switches More... •  Sanofi (France) (SAN.PA)-Genzyme Corporation (GENZ)'s MS Drug Lemtrada Beats Rebif in Head-to-head Phase III Showdown More... •  Novartis AG (NVS) Drug SigniforR Gets EU Approval as the First Medication to Treat Patients With Cushing's Disease More... •  GlaxoSmithKline (GSK) Insists it is the Best Owner for Human Genome Sciences, Inc. (HGSI) More... •  Salix Pharmaceuticals, Ltd. (SLXP), Progenics Pharmaceuticals, Inc. (PGNX) Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012 More... •  Johnson & Johnson (JNJ) CEO Under Fire for Big Bonuses Amid Scandals More... More Top News Crown Bioscience Inc. leads the field in providing unique translational platforms and cost effective drug discovery solutions for its biotech and pharmaceutical partners in dedicated therapeutic areas: Oncology and Metabolic Disease. Our multi-disciplinary team of experts, headquartered in the heart of Silicon Valley, with wholly own research facilities in Kanapolis, Beijing (China), and Taicang (China)., provides an integrated service solution from your idea to an enabling IND, including: preclinical, translational and clinical capabilities. CrownBio offers a truly integrated approach to undertaking complete drug discovery programs as well as hit identification, hit-to-lead, and lead optimization projects. To learn more about our unique portfolio and breadth of services, visit www.crownbio.com or call us at 603-686-9330 •  How the FDA Stifles New Cures, Part I: The Rising Cost of Clinical Trials More... •  Novartis Corporation (NVS) Sits in the Penalty Box More... •  BioPharm Executive: Shareholders Before Patients? More... •  Oregano Shown To Effectively Destroy Prostate Cancer Cells, Long Island University Study More... •  Fish Oil Could be Therapy for Periodontal Disease, University of South Australia Reveals More... •  Yes...Yes...No? G Spot Finding Fails to Convince, Institute of Gynecology Study More... •  Botox Ingredient Has Limited Effect on Headaches, Medical College of Wisconsin Study More... •  Does Fatty Food Impact Marital Stress? Ohio State University Medical Center Study More...   More Featured News BioContact Quebec October 3-4, 2012 Chateau Laurier Quebec 1220 Place Biopharmaceutical partnership symposium that is expecting more than 500 participants representing all sectors of the industry. namely biopharmaceutical and pharmaceutical companies, universities, venture capital, consulting and governmental organizations. Fo rmore information, please visit: www.biocontact.ca. Vaccines Market Access in India - New Vaccine Uptake Drives Growth • Review the current regulatory processes, pricing mechanisms, and vaccination schedule in India. • Identify major multinational and domestic players, view their product portfolios and pipelines, and understand their expansion strategies.. • Examine the major drivers and resistors of the current Indian vaccine market and understand the key opportunities and threats facing developers. Click Here for More Information. Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! • Pharm Country (Somerville, New Jersey) Heron Health Director - Evidence, Pricing & Access Ensuring that all projects are being conducted in an efficient manner and that quality and client satisfaction is maximized at all times, and that the direction of the project and quality of the deliverables meet both the project objectives and the client needs. • Biotech Beach (Santa Monica, California) Astellas Pharma US Environmental Health and Safety Officer Will facilitate compliance with all applicable environmental, health, and safety principles, guidelines, and legal requirements; deliver, coordinate, and track lab safety training activities; create and maintain company safety practices and manuals; coordinate safety inspections and direct the EH&S program. • Rocky Bio (Salt Lake City, Utah) Watson Pharmaceuticals, Inc. Manager, Regulatory Affairs Proprietary Under general direction, functions as primary regulatory contact with regulatory authorities for assigned products and projects. Manages preparation of regulatory submissions, briefing packages and presentations for regulatory agency meetings. Determines nature, scope and format of information to be generated in order to successfully: file and maintain INDs/CTAs; file regulatory dossiers; respond to health authority inquiries; maintain product registrations and obtain international market access. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Medical Director, Pharmacovigilance Serves as the Global Safety Lead physician for complex, strategically important developmental programs especially those that are Phase III and IV programs. Responsible for the oversight of signal detection and risk management activities for designated global products. Ensures patient safety is adequately addressed in TGRD sponsored studies. • Genetown (Cambridge, Massachusetts) AVEO Pharmaceuticals, Inc. Scientist, Pharmacology Will lead and participate in the evaluation of antibody drug candidates in relevant in vivo models of cancer including proof of concept, target validation, PK/PD relationships as well as efficacy. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! BioCapital Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Mid-Atlantic region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • BioCapital Career Fair, Bethesda, MD April 25, 2012 • Pharm Country Career Fair, King Of Prussia, PA May 1, 2012 • BioNC Career Fair, Durham, NC May 2, 2012 • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Gilead Sciences, Inc. (Seattle, WA) 199 East Blaine Street Seattle, Washington 98102 U.S.A. Phone: 206-728-5090 Fax: 206-728-5095 Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia. More Company Profiles FREE Subscription to Lab Manager Magazine Lab Manager Magazine helps provide a forum and a framework to help lab professionals hire and supervise staff, establish a laboratory, and plan a coherent research program, while keeping the goals of good science and scientific discovery at the forefront. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.